AllI · Sterile fill-finish capacityII · Stoppers, syringes & drug-contact componentsIII · Pharmaceutical glass & vialsIV · Bioprocessing consumables & resinsV · API & small-molecule reshoringVI · CDMO capacity & the China exodusVII · Peptide & oligonucleotide manufacturingVIII · Sterile injectables & shortage economicsIX · Analytical instruments & QC releaseX · Private giants & exposure vehicles
| Ticker | Name | Tier ↓ | Quote | Mkt cap | 6M | Chokepoints |
|---|---|---|---|---|---|---|
| A | Agilent Technologies, Inc. | core | $143.12-1.1% | $37.0B | +28.3% | peptides-oligos · instruments-qc |
| DHR | Danaher Corporation | core | $200.53-2.1% | $128.0B | +7.1% | bioprocessing · instruments-qc |
| TMO | Thermo Fisher Scientific Inc. | core | $603.18-0.4% | $180.0B | +29.9% | fill-finish · bioprocessing · api-reshoring · cdmo-capacity · instruments-qc |
| WAT | Waters Corporation | core | $401.64-0.8% | $36.0B | +40.2% | instruments-qc |
| BMXMF | bioMerieux S.A. | watch | $86.11-0.0% | $8.6B | -28.4% | instruments-qc |
| CRL | Charles River Laboratories International, Inc. | watch | $273.00-1.9% | $8.9B | +75.6% | cdmo-capacity · instruments-qc |
| MTD | Mettler-Toledo International | watch | $1280.58-0.8% | $23.0B | +9.1% | instruments-qc |
Quote shows the latest price and daily change; the 6M column is the total return over that window. Quotes delayed up to 15 minutes; tiers are editorial conviction, not ratings. Click a column header to sort.